|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2009-7-13
|
|
pubmed:abstractText |
NSC 333003 has been identified from the NCI Diversity Set as an inhibitor of the MDM2-p53 protein-protein interaction by in silico docking (virtual screening). Its potency and chemical characteristics render it well suited for lead optimization studies that can result in more potent analogs with improved drug-like properties. Its synthesis was achieved using an acid catalyzed condensation reaction from commercially available benzothiazole hydrazine and pyridyl phenyl ketone in refluxing methanol. Stereochemical implications for this compound are described.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-10966738,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-11805837,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-11891322,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-12501160,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-14704432,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-15027865,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-15027866,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-15715460,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-15956260,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-15999986,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-17875722,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-18042718,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-18075579,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-18266348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-18316739,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-8788213,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-9223638,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19457663-9382809
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1464-3405
|
|
pubmed:author |
pubmed-author:ChenJiandongJ,
pubmed-author:GuidaWayne CWC,
pubmed-author:LawrenceHarshani RHR,
pubmed-author:LawrenceNicholas JNJ,
pubmed-author:LiZhenyuZ,
pubmed-author:McLaughlinMark LML,
pubmed-author:McManusGregory JGJ,
pubmed-author:SebtiSaïd MSM,
pubmed-author:SungShen-ShuSS,
pubmed-author:YipM L RichardML,
pubmed-author:ZaworotkoMichael JMJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3756-9
|
|
pubmed:dateRevised |
2010-9-27
|
|
pubmed:meshHeading |
pubmed-meshheading:19457663-Animals,
pubmed-meshheading:19457663-Benzothiazoles,
pubmed-meshheading:19457663-Cell Line, Tumor,
pubmed-meshheading:19457663-Computer Simulation,
pubmed-meshheading:19457663-Crystallography, X-Ray,
pubmed-meshheading:19457663-Enzyme Inhibitors,
pubmed-meshheading:19457663-Hydrazines,
pubmed-meshheading:19457663-Mice,
pubmed-meshheading:19457663-Molecular Conformation,
pubmed-meshheading:19457663-Protein Interaction Domains and Motifs,
pubmed-meshheading:19457663-Proto-Oncogene Proteins c-mdm2,
pubmed-meshheading:19457663-Stereoisomerism,
pubmed-meshheading:19457663-Structure-Activity Relationship,
pubmed-meshheading:19457663-Tumor Suppressor Protein p53
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Identification of a disruptor of the MDM2-p53 protein-protein interaction facilitated by high-throughput in silico docking.
|
|
pubmed:affiliation |
Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|
